(Q28286926)

English

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1

scientific article

In more languages

Statements

scholarly article

0 references

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1 (English)

0 references

multiple drug resistance

0 references

bilirubin metabolic disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Vicente Soriano

8

object named as

Vincent Soriano

0 references

author name string

Sonia Rodríguez Nóvoa

1

0 references

Pablo Barreiro

2

0 references

Ana Rendón

3

0 references

Ana Barrios

4

0 references

Angélica Corral

5

0 references

Inmaculada Jiménez-Nacher

6

0 references

Juan González-Lahoz

7

0 references

language of work or name

0 references

publication date

15 January 2006

0 references

Clinical Infectious Diseases

0 references

42

0 references

2

0 references

291-5

0 references

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Predictors of virological response to atazanavir in protease inhibitor-experienced patients

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Atazanavir: the advent of a new generation of more convenient protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F499056

21 January 2018

Identifiers

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28286926&oldid=1224993290"